K Pharma,Inc. (TYO:4896)
675.00
-11.00 (-1.60%)
Nov 18, 2026, 10:13 AM JST
K Pharma,Inc. Market Cap
K Pharma,Inc. has a market cap or net worth of 7.85 billion as of November 17, 2026. It is the 29,674th most valuable company in the world and the 2,638th biggest in Japan. Its market cap has increased by 4.01% in one year.
Market Cap
7.85B
Enterprise Value
7.44B
Revenue
n/a
Global Rank
Country Rank
#2,638 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since October 17, 2023, K Pharma,Inc.'s market cap has decreased from 10.95B to 7.85B, a decrease of -28.33%. That is a compound annual growth rate of -10.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 7.85B | 2.43% |
| Dec 30, 2025 | 7.66B | 6.28% |
| Dec 30, 2024 | 7.21B | -13.75% |
| Dec 29, 2023 | 8.36B | -23.67% |
| Oct 17, 2023 | 10.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kubota Pharmaceutical Holdings | 8.59B |
| Immuno-Biological Laboratories | 8.54B |
| Kidswell Bio | 7.49B |
| Carna Biosciences | 7.37B |
| StemRIM | 7.33B |
| ADR Biomedical Holdings | 7.14B |
| CellSeed | 6.68B |
| StemCell Institute | 6.56B |